Search research articles
Contact Us
Filters
Showing results (111-120 of 297) with videos related to
Page
of 30
Sort By:
EJNMMI Research
|
July 22, 2021
N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [<sup>18</sup>F]FDG PET/CT compared to the histopathology reference standard
Hubertus Hautzel, Yazan Alnajdawi, Wolfgang P Fendler, et al.
Cancer Medicine
|
May 1, 2020
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
Anja Welt, Marcel Wiesweg, Sarah Theurer, et al.
Radiation Oncology (London, England)
|
July 16, 2022
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
Nika Guberina, Christoph Pöttgen, Martin Schuler, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
December 22, 2025
Impact of lymph node metastasis patterns on long-term survival in upper lobe non-small cell lung cancer
Nikolas Achilleos, Inna Schott, Fabian Doerr, et al.
Pathology Oncology Research : POR
|
July 14, 2021
Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors
Daniel Valdivia, Danjouma Cheufou, Benjamin Fels, et al.
BMC Cancer
|
January 8, 2022
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
Michael Wessolly, Susann Stephan-Falkenau, Anna Streubel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2026
Pretherapeutic prognostic factors for survival under chemoimmunotherapy/immunotherapy of advanced NSCLC patients
Julija Judickiene, Martin Metzenmacher, Gregor Zaun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 13, 2025
Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)
Kristof Cuppens, Marcel Wiesweg, Paul Baas, et al.
Journal of Extracellular Biology
|
June 8, 2026
Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient Plasma
Tobias Tertel, Fabiola Nardi Bauer, Oumaima Stambouli, et al.
Cancer Research
|
April 12, 2013
DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors
Susanne Simon, Florian Grabellus, Loretta Ferrera, et al.
Page
of 30
Search research articles
Search
Showing results (111-120 of 297) with videos related to
Sort By:
Page
of 30
EJNMMI Research
|
July 22, 2021
N-staging in large cell neuroendocrine carcinoma of the lung: diagnostic value of [<sup>18</sup>F]FDG PET/CT compared to the histopathology reference standard
Hubertus Hautzel, Yazan Alnajdawi, Wolfgang P Fendler, et al.
Cancer Medicine
|
May 1, 2020
Buparlisib in combination with tamoxifen in pretreated patients with hormone receptor-positive, HER2-negative advanced breast cancer molecularly stratified for PIK3CA mutations and loss of PTEN expression
Anja Welt, Marcel Wiesweg, Sarah Theurer, et al.
Radiation Oncology (London, England)
|
July 16, 2022
Long-term survival of patients with central or > 7 cm T4 N0/1 M0 non-small-cell lung cancer treated with definitive concurrent radiochemotherapy in comparison to trimodality treatment
Nika Guberina, Christoph Pöttgen, Martin Schuler, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
December 22, 2025
Impact of lymph node metastasis patterns on long-term survival in upper lobe non-small cell lung cancer
Nikolas Achilleos, Inna Schott, Fabian Doerr, et al.
Pathology Oncology Research : POR
|
July 14, 2021
Potential Prognostic Value of Preoperative Leukocyte Count, Lactate Dehydrogenase and C-Reactive Protein in Thymic Epithelial Tumors
Daniel Valdivia, Danjouma Cheufou, Benjamin Fels, et al.
BMC Cancer
|
January 8, 2022
Digital gene expression analysis of NSCLC-patients reveals strong immune pressure, resulting in an immune escape under immunotherapy
Michael Wessolly, Susann Stephan-Falkenau, Anna Streubel, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 4, 2026
Pretherapeutic prognostic factors for survival under chemoimmunotherapy/immunotherapy of advanced NSCLC patients
Julija Judickiene, Martin Metzenmacher, Gregor Zaun, et al.
European Journal of Cancer (Oxford, England : 1990)
|
December 13, 2025
Long-term outcomes of preoperative nivolumab with or without relatlimab in patients with resectable non-small-cell lung cancer (NEOpredict-Lung)
Kristof Cuppens, Marcel Wiesweg, Paul Baas, et al.
Journal of Extracellular Biology
|
June 8, 2026
Single-EV Analyses Require Rigorous Antibody Qualification: PD-L1 Profiling in Cell Models and Patient Plasma
Tobias Tertel, Fabiola Nardi Bauer, Oumaima Stambouli, et al.
Cancer Research
|
April 12, 2013
DOG1 regulates growth and IGFBP5 in gastrointestinal stromal tumors
Susanne Simon, Florian Grabellus, Loretta Ferrera, et al.
Page
of 30